CN101065148A
|
|
Conjugated complement cascade inhibitors
|
US7482376B2
|
|
Conjugated complement cascade inhibitors
|
CN1723036A
|
|
Methods of increasing platelet and hematopoietic stem cell production
|
WO2004003683A2
|
|
Conformational sampling by self-organization
|
MXPA04011671A
|
|
Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions.
|
AU2003235504A8
|
|
Method for cytoprotection through mdm2 and hdm2 inhibition
|
NZ532463A
|
|
Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
|
CA2462000A1
|
|
Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes
|
MXPA04001815A
|
|
Conductive microtiter plate.
|
US2003018064A1
|
|
Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
|
WO02061419A1
|
|
Method, system, and computer program product for analyzing combinatorial libraries
|
US2002070208A1
|
|
Microtiter plate with integral heater
|
ZA200303091B
|
|
Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl-substituted phenyl acetamides as protease inhibitors.
|
US6486174B2
|
|
Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists
|
CA2419600A1
|
|
Method, system, and computer program product for determining properties of combinatorial library products from features of library building blocks
|
US2002037897A1
|
|
Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists
|
MXPA03000963A
|
|
Cyclic oxyguanidine protease inhibitors.
|
AU7892701A
|
|
Cyclic oxyguanidine pyrazinones as protease inhibitors
|
AU5974301A
|
|
Gpcr 4-helix and 5-helix bundles
|
WO0175790A2
|
|
Method, system, and computer program product for representing object relationships in a multidimensional space
|